{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:19:23Z","timestamp":1761016763228},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s00125-008-0990-3","type":"journal-article","created":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T12:18:59Z","timestamp":1207138739000},"page":"956-961","source":"Crossref","is-referenced-by-count":17,"title":["Long-term prevention of diabetic nephropathy: an audit"],"prefix":"10.1007","volume":"51","author":[{"given":"K. J.","family":"Schjoedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tarnow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-H.","family":"Parving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"990_CR1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1530\/acta.0.1000550","volume":"100","author":"H-H Parving","year":"1982","unstructured":"Parving H-H, Oxenb\u00f8ll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy. Acta Endocrinol 100:550\u2013555","journal-title":"Acta Endocrinol"},{"key":"990_CR2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"i","author":"GC Viberti","year":"1982","unstructured":"Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430\u20131432","journal-title":"Lancet"},{"key":"990_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","volume":"311","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89\u201393","journal-title":"N Engl J Med"},{"key":"990_CR4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF00262210","volume":"26","author":"ER Mathiesen","year":"1984","unstructured":"Mathiesen ER, Oxenb\u00f8ll B, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26:406\u2013410","journal-title":"Diabetologia"},{"key":"990_CR5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(86)91433-9","volume":"ii","author":"B Feldt-Rasmussen","year":"1986","unstructured":"Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet ii:1300\u20131304","journal-title":"Lancet"},{"key":"990_CR6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.297.6656.1092","volume":"297","author":"M Marre","year":"1988","unstructured":"Marre M, Chatellier G, Leblanc H, Guyenne T-T, M\u00e9nard J, Passa P (1988) Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297:1092\u20131095","journal-title":"BMJ"},{"key":"990_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","volume":"303","author":"ER Mathiesen","year":"1991","unstructured":"Mathiesen ER, Hommel E, Giese J, Parving H-H (1991) Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. BMJ 303:81\u201387","journal-title":"BMJ"},{"key":"990_CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s001250050136","volume":"37","author":"H-J Bangstad","year":"1994","unstructured":"Bangstad H-J, \u00d8sterby R, Dahl-J\u00f8rgensen K, Berg K, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483\u2013490","journal-title":"Diabetologia"},{"key":"990_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00403306","volume":"39","author":"The Microalbuminuria Captopril Study Group","year":"1996","unstructured":"The Microalbuminuria Captopril Study Group (1996) Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 39:587\u2013593","journal-title":"Diabetologia"},{"key":"990_CR10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diacare.21.1.104","volume":"21","author":"G Crepaldi","year":"1998","unstructured":"Crepaldi G, Carta Q, Deferrari G et al (1998) Effects of lisinopril and nifedipine on the progression of overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. Diabetes Care 21:104\u2013110","journal-title":"Diabetes Care"},{"key":"990_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.319.7201.24","volume":"319","author":"ER Mathiesen","year":"1999","unstructured":"Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving H-H (1999) Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 319:24\u201325","journal-title":"BMJ"},{"key":"990_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","volume":"271","author":"GC Viberti","year":"1994","unstructured":"Viberti GC, Mogensen CE, Groop L, Pauls JF, the European Microalbuminuria Captopril Study Group (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271:275\u2013279","journal-title":"JAMA"},{"key":"990_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0002-9343(99)80226-5","volume":"99","author":"LMB Laffel","year":"1995","unstructured":"Laffel LMB, McGill JB, Gans JD (1995) The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 99:497\u2013504","journal-title":"Am J Med"},{"key":"990_CR14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(96)10244-0","volume":"349","author":"The Euclid Study Group","year":"1997","unstructured":"The Euclid Study Group (1997) Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349:1787\u20131792","journal-title":"Lancet"},{"key":"990_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-134-5-200103060-00009","volume":"134","author":"The ACE Inhibitors in Diabetic Nephropathy Trialist Group","year":"2001","unstructured":"The ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001) Should all type 1 diabetic microalbuminuric patients receive ACE inhibitors? A meta-regression analysis. Ann Intern Med 134:370\u2013379","journal-title":"Ann Intern Med"},{"key":"990_CR16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"H-H Parving","year":"2001","unstructured":"Parving H-H, Lehnert H, Br\u00f6chner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870\u2013878","journal-title":"N Engl J Med"},{"key":"990_CR17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","volume":"346","author":"CE Mogensen","year":"1995","unstructured":"Mogensen CE, Keane WF, Bennett PH et al (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080\u20131084","journal-title":"Lancet"},{"key":"990_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00365510152567112","volume":"61","author":"HP Hansen","year":"2001","unstructured":"Hansen HP, Lund SS, Rossing P et al (2001) Preventing diabetic nephropathy: an audit. Scand J Clin Lab Invest 61:471\u2013477","journal-title":"Scand J Clin Lab Invest"},{"key":"990_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"990_CR20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1523-1755.2005.00556.x","volume":"68","author":"P Rossing","year":"2005","unstructured":"Rossing P, Hougaard P, Parving H-H (2005) Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study. Kidney Int 68:1446\u20131450","journal-title":"Kidney Int"},{"key":"990_CR21","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1523-1755.2005.00521.x","volume":"68","author":"AS Astrup","year":"2005","unstructured":"Astrup AS, Tarnow L, Rossing P, Pietraszek L, Hansen PR, Parving H-H (2005) Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 68:1250\u20131257","journal-title":"Kidney Int"},{"key":"990_CR22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/bmj.305.6861.1051","volume":"305","author":"CM Forsblom","year":"1992","unstructured":"Forsblom CM, Groop P-H, Ekstrand A, Groop L (1992) Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 305:1051\u20131053","journal-title":"BMJ"},{"key":"990_CR23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00125-004-1413-8","volume":"47","author":"F Giorgino","year":"2004","unstructured":"Giorgino F, Laviola L, Cavallo PP, Solnica B, Fuller J, Chaturvedi N (2004) Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 47:1020\u20131028","journal-title":"Diabetologia"},{"key":"990_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.17.2.120","volume":"17","author":"T Almdal","year":"1994","unstructured":"Almdal T, N\u00f8rgaard K, Feldt-Rasmussen B, Deckert T (1994) The predictive value of microalbuminuria in IDDM. Diabetes Care 17:120\u2013125","journal-title":"Diabetes Care"},{"key":"990_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2337\/diabetes.49.1.94","volume":"49","author":"JH Warram","year":"2000","unstructured":"Warram JH, Scott LJ, Hanna LS et al (2000) Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes 49:94\u2013100","journal-title":"Diabetes"},{"key":"990_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.306.6871.175","volume":"306","author":"M Hallab","year":"1993","unstructured":"Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M (1993) Comparison of reduction in microalbuminuria by enalapril and hydrochlorthiazide in normotensive patients with insulin dependent diabetes. BMJ 306:175\u2013182","journal-title":"BMJ"},{"key":"990_CR27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.313.7060.779","volume":"313","author":"P Rossing","year":"1996","unstructured":"Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H (1996) Predictors of mortality in insulin dependent diabetes: 10 year follow-up study. BMJ 313:779\u2013784","journal-title":"BMJ"},{"key":"990_CR28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D Zeeuw de","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving H-H et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921\u2013927","journal-title":"Circulation"},{"key":"990_CR29","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","volume":"65","author":"D Zeeuw de","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving H-H et al (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65:2309\u20132320","journal-title":"Kidney Int"},{"key":"990_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.0000154082.72286.2a","volume":"45","author":"H Ibsen","year":"2005","unstructured":"Ibsen H, Olsen MH, Wachtell K et al (2005) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 45:198\u2013202","journal-title":"Hypertension"},{"key":"990_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487\u2013497","journal-title":"N Engl J Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-0990-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-008-0990-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-0990-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:46:11Z","timestamp":1558611971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-008-0990-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,3]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1007\/s00125-008-0990-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,3]]}}}